Progress in diagnosis and treatment of Libman-Sacks endocarditis

Abstract:Libman-Sacks endocarditis is an aseptic endocarditis that occurs spontaneously in patients with systemic lupus erythematosus and antiphospholipid syndrome. Since it was first described by Libman and Sacks in 1924, the diagnosis and treatment of the syndrome and its causal relationship have been the subject of extensive discussion in the field of cardiology and systemic autoimmune diseases. Recent research findings and clinical practice have found that this disease is closely related to lupus and antiphospholipid antibody syndrome. Patients often have valvular lesions, which increase the risk of heart damage and thrombotic complications. At present, remarkable progress has been made in the diagnosis and treatment of Libman-Sacks endocarditis, but there are still some challenges in the diagnosis and treatment.